Integrin and Matrix Metalloproteinase Expression in Human Carotid Plaque

Journal of Surgical Research

Volumn 155, Issue 1, 2009, Pages 157-164

  Murillo, Carlos A ^a   Woodside, Kenneth J ^a   Guo, Qian ^a   Zhang, Shu ^a   O'Connor, Kathleen L ^a   Hunter, Glenn C ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

atherosclerosis; carotid endarterectomy; carotid restenosis; carotid stenosis; cDNA gene array; extracellular matrix; human tissue; integrins; matrix metalloproteinases

Indexed keywords

ALPHA2 INTEGRIN; ALPHA6 INTEGRIN; BETA3 INTEGRIN; COMPLEMENTARY DNA; GELATINASE A; GELATINASE B; INTEGRIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTERY INTIMA; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ATHEROSCLEROSIS; CAROTID STENOSIS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; HUMANS; INTEGRINS; METALLOPROTEASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECURRENCE;

EID: 67349233432     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.08.005     Document Type: Article

References (23)

1. Stoney R.J., and String S.T. Recurrent carotid stenosis. Surgery 80 (1976) 705
2. Zierler R.E., Bandyk D.F., Thiele B.L., et al. Carotid artery stenosis following endarterectomy. Arch Surg 117 (1982) 1408
3. Bertin V.J., Plecha F.R., Rogers G.J., et al. Recurrent stenosis by duplex scan following carotid endarterectomy. Arch Surg 124 (1989) 866
4. Mattos M.A., Shamma A.R., Rossi N., et al. Is duplex follow-up cost-effective in the first year after carotid endarterectomy?. Am J Surg 156 (1988) 91
5. Woodside K.J., Hernandez A., Smith F.W., et al. Differential gene expression in primary and recurrent carotid stenosis. Biochem Biophys Res Commun 302 (2003) 509
6. Heeneman S., Cleutjens J.P., Faber B.C., et al. The dynamic extracellular matrix: Intervention strategies during heart failure and atherosclerosis. J Pathol 200 (2003) 516
7. Raines E.W. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: Relationships to vascular disease. Int J Exp Pathol 81 (2000) 173
8. Moiseeva E.P. Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc Res 52 (2001) 372
9. Kieny R., Seiller C., and Petit H. Evolution of carotid restenosis after endarterectomy. Cardiovasc Surg 2 (1994) 555
10. Loftus I.M., Naylor A.R., Goodall S., et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 31 (2000) 40
11. Clowes A.W., Reidy M.A., and Clowes M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 49 (1983) 327
12. Choudhary S., Higgins C.L., Chen I.Y., et al. Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues. Arterioscler Thromb Vasc Biol 26 (2006) 2351
13. Tyagi S.C., Meyer L., Schmaltz R.A., et al. Proteinases and restenosis in the human coronary artery: Extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis 116 (1995) 43
14. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17 (2001) 463
15. Zhu Y., Farrehi P.M., and Fay W.P. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice. Circulation 103 (2001) 3105
16. Zhou H.M., Nichols A., Meda P., et al. Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis. Embo J 19 (2000) 4817
17. Mondino A., and Blasi F. uPA and uPAR in fibrinolysis, immunity, and pathology. Trends Immunol 25 (2004) 450
18. Noda-Heiny H., Daugherty A., and Sobel B.E. Augmented urokinase receptor expression in atheroma. Arterioscler Thromb Vasc Biol 15 (1995) 37
19. Dollery C.M., and Libby P. Atherosclerosis and proteinase activation. Cardiovasc Res 69 (2006) 625
20. Naoum J., Zhang S., Woodside K.J., et al. Therapeutic modification of the fibrous cap of atherosclerotic lesions in APO-E knockout mice: Differing effects of rosiglitazone, rapamycin and simvastatin. Cardiovasc Pathol 13 (2004) S139
21. Plekhanova O., Parfyonova Y., Bibilashvily R., et al. Urokinase plasminogen activator augments cell proliferation and neointima formation in injured arteries via proteolytic mechanisms. Atherosclerosis 159 (2001) 297
22. Stepanova V., Mukhina S., Kohler E., et al. Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms. Mol Cell Biochem 195 (1999) 199
23. Czekay R.P., Aertgeerts K., Curriden S.A., et al. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. J Cell Biol 160 (2003) 781